A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Imatinib Dimer Impurity 1 - Request Quote

Picture of Imatinib Dimer Impurity 1

Imatinib Dimer Impurity 1

SZ CAT No:SZ-I004055
CAS No
NA
Mol.F.
C33H28N10O
Mol.Wt.
580.7
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Imatinib Dimer Impurity 1 is chemically 1,3-Bis(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)urea. Imatinib Dimer Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Imatinib Dimer Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Imatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Imatinib Dimer Impurity 1

Purchase Imatinib Dimer Impurity 1

Imatinib Dimer Impurity 1 suppliers

Imatinib Dimer Impurity 1 manufacturers

Imatinib Dimer Impurity 1 price

Order Imatinib Dimer Impurity 1

Enquire Imatinib Dimer Impurity 1

Imatinib Dimer Impurity 1 cost

Imatinib Dimer Impurity 1 Supplier

Imatinib Dimer Impurity 1 Distributor

Imatinib Dimer Impurity 1 for Method Validation

Imatinib Reference Standard

Imatinib Dimer Impurity 1 for ANDA Filing

Imatinib Dimer Impurity 1 for Forced Degradation Studies

Imatinib Dimer Impurity 1 Identification Standards

Imatinib Dimer Impurity 1 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,